- Advertise
- Contact Us
- Contribute
- Editorial Info
- Terms and Conditions
- Privacy Policy
- Do Not Sell My Personal Information
- About Us
© 2023 MJH Life Sciences™ and Endocrinology Network. All rights reserved.
American Association of Clinical Endocrinology
Coverage of the American Association of Clinical Endocrinology's Annual Meeting.
Diabetes Dialogue: Tirzepatide in Action & AACE 2022 Recap
May 20, 2022
In this episode of Diabetes Dialogue, hosts Drs. Isaacs and Bellini take a deep dive into the tirzepatide approval, including discussions around the mechanism of action, dose titrations, and where it might fit in the upcoming ADA standards of care. Later in the episode, hosts recap their experiences from AACE 2022, which saw the release of new guidelines for NAFLD.
Diabetic Ketoacidosis Raises Risk of In-Hospital Mortality, Hospital Readmission in Heart Failure
May 17, 2022
Diabetic ketoacidosis increased the likelihood of in-hospital mortality by 61%, the likelihood of major adverse cardiovascular events by 56%, and a likelihood of 30-day readmission by 12% among patients hospitalized with heart failure in the US.
Thyroid Dysfunction Could Increase Risk of Parkinson Disease
May 13, 2022
A systematic review and meta-analysis from AACE 2022 provides an overview of the potential associations between thyroid dysfunction, including both hypothyroidism and hyperthyroidism, and risk of Parkinson disease.
Withdrawal Study Details Effects of Levoketoconazole in Cushing's Syndrome
May 12, 2022
Data presented at AACE 2022 detail levoketoconazole-specific effects observed among patients with endogenous Cushing's syndrome from the phase 3 LOGICS trial.
Study Details Impact of Diabetes on Disease Presentation Among Patients with Thyroid Eye Disease
June 02, 2021
Analysis of claims data from the Symphony database offers clinicians greater insight into the impact of diabetes, both type 1 and type 2, on thyroid eye disease in US patients.
AACE 2021 Analysis Details Risk of Cardiovascular Disease, AFib, and CV Death in Thyroid Cancer Patients
June 02, 2021
A systematic review and meta-analysis presented at AACE 2021 details the risk of cardiovascular disease in patients with thyroid cancer who have undergone thyroidectomy.
Age, Disease History Play Role in Developing Peripheral Artery Disease in Patients with Diabetes
June 01, 2021
A systematic review and meta-analysis presented at AACE 2021 shed light on risk factors associated with increased odds of developing peripheral artery disease among patients with type 2 diabetes.
Phase 1 Trial Indicates Liquid Formulation of Levothyroxine Safe to Administer as Early as 15 Minutes Before Breakfast
June 01, 2021
Data from a phase 1 trial comparing dosing 15 and 30 minutes prior to breakfast suggests the wait time between intake of the novel liquid formulation of levothyroxine, Tirosint-SOL, and breakfast could be shortened to 15 minutes.
Starting CGM Use at Hospital Discharge Did Not Reduce Readmission Risk in Type 2 Diabetes Patients
May 30, 2021
Despite the investigators' hypothesis, implementing use of CGM at hospital discharge did not reduce risk of emergency department visits or rehospitalizations among patients with uncontrolled type 2 diabetes.
CGM Use, Visits with Diabetes Educator or Nutritionist Reduce Care Gap Between Pediatric and Adult Diabetes
May 29, 2021
A retrospective analysis of EHR data suggests use of CGM or visits from a diabetes educator or nutritionist were associated with a decrease in gaps between receiving care at a pediatric endocrinology clinic and an adult clinic among patients transitioning from pediatric to adult diabetes.